Cefotaxime-associated encephalopathy in peritoneal dialysis patients: A case report

This case emphasizes the importance of considering the potential adverse effects of antibiotics, particularly in patients with kidney insufficiency undergoing dialysis. This highlights the necessity of vigilance in monitoring drug-related complications for timely detection of encephalopathic symptoms and development of individualized treatment strategies. We acknowledge that cefotaxime may increase the risk of CAE in patients on peritoneal dialysis, necessitating heightened awareness among physicians.